Escagen Corp said an initial
offering of two mln common shares is underway at nine dlrs each
through underwriters led by &lt;Prudential-Bache Group Inc>.
    The company is purchasing the assets and business of
International Plant Research Institute and will apply plant
biotechnology to developing food products and planting
materials.
 Reuter
&#3;